Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Metrics for Quant Score Make GlaxoSmithKline (GSK) a Sell

By Portfolio Grader
GlaxoSmithKline Plc (NYSE:GSK) is a constituent of the 133 company Pharmaceuticals GICS industry group, which is part of the 781 company GICS Health Care sector. GSK has a market value of $85.7 billion which is in the top 10% of its industry group. The ranking for GSK by Portfolio Grader places it 87 among the 133 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 503 among the 781 companies in the sector, and number 3,192 in the nearly 5,000 company Portfolio Grader universe.

Adverse Industry Group Rank Keep Schlumberger (SLB) a Sell

By Portfolio Grader
Schlumberger NV (NYSE:SLB) is one of 73 companies within the Energy Equipment & Services GICS industry group, which is in turn part of the 363 company GICS Energy sector. SLB has a market value of $85.8 billion which is in the top decile in its industry group. The current Portfolio Grader ranking for SLB puts it 61 among the 73 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 314 among the 363 companies in the sector, and number 4,236 in the nearly 5,000 company Portfolio Grader universe.

Analytics for Quant Score Drive Upgrade of Eli Lilly (LLY) to Buy

By Portfolio Grader
The current recommendation of Buy for Eli Lilly and Company (NYSE:LLY) is the result of using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. LLY has been upgraded from a Hold to a Buy in the last week.

Earnings Momentum Make NTT Docomo (DCM) a Buy

By Portfolio Grader
NTT Docomo Inc (NYSE:DCM) is one of 21 companies within the Wireless Telecommunication Services GICS industry group, which is in turn part of the 66 company GICS Telecommunication Services sector. DCM has a market value of $92.5 billion which is in the top 10% of its industry group. The ranking for DCM by Portfolio Grader places it 7 among the 21 companies in this industry group, putting it in the second quartile; in the top quartile of the sector with a ranking of 16 among the 66 companies in the sector, and number 838 in the nearly 5,000 company Portfolio Grader universe.

High-Level Quant Score Keeps Novo Nordisk A/S (NVO) a Strong Buy

By Portfolio Grader
Novo Nordisk A/S (NYSE:NVO) is one of the 781 companies in the GICS Health Care sector, and a component of the 133 company Pharmaceuticals GICS industry group within this sector. NVO's market value is $99.9 billion which falls in the top decile in its industry group. The stock's current Portfolio Grader score places it 4 among the 133 companies in this industry group, putting it in the top decile; among the sector leaders with a ranking of 48 among the 781 companies in the sector, and number 254 in the nearly 5,000 company Portfolio Grader universe.

Anemic Quant Score Restrict Bristol-Myers Squibb Co (BMY) Rating

By Portfolio Grader
Bristol-Myers Squibb Co (NYSE:BMY) is ranked as a Hold using the system for investing of Louis Navellier and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking BMY has had from Portfolio Grader for 2 months.

Sanofi (SNY) Earnings Growth Hurt Rating

By Portfolio Grader
Portfolio Grader currently ranks Sanofi SA (NYSE:SNY) a Hold. The system for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. SNY has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.

Motif Bio (MTFB) Sees Rating Drop….. Wilting Earnings Growth

By Portfolio Grader
Portfolio Grader currently ranks Motif Bio Plc (NULL:MTFB) a Hold. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. The shares have been downgraded from a Strong Buy to a Hold in the last week.

BP (BP) a Strong Buy on High-Level Sales Growth

By Portfolio Grader
With a $129.0 billion market value, BP Plc (NYSE:BP) ranks in the top decile in its industry group, Oil Gas & Consumable Fuels, and in the top 10% of its sector group, Energy, in market value. From the vantage point of investment attractiveness, the stock's current Portfolio Grader score places it 9 among the 290 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 9 among the 363 companies in the sector, and number 361 in the nearly 5,000 company Portfolio Grader universe.

Sales Growth Keeps Total (TOT) Shares a Buy

By Portfolio Grader
The current recommendation of Buy for Total SA (NYSE:TOT) has been derived by using the methods of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Superb Analytics for Earnings Growth Keep Royal Dutch Shell (RDS.A) a Strong Buy

By Portfolio Grader
Royal Dutch Shell Plc (NYSE:RDS.A) is a constituent of the 290 company Oil Gas & Consumable Fuels GICS industry group, which is a segment of the 363 company GICS Energy sector. RDS.A's market value is $140.6 billion which falls in the top decile in its industry group. The stock's current Portfolio Grader score places it 2 among the 290 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 2 among the 363 companies in the sector, and number 81 in the nearly 5,000 company Portfolio Grader universe.

Analytics for Quant Score Make Merck & Co (MRK) a Sell

By Portfolio Grader
Merck & Co (NYSE:MRK) is one of 133 companies within the Pharmaceuticals GICS industry group, which is in turn part of the 781 company GICS Health Care sector. MRK's market value is $150.5 billion which falls in the top 10% of its industry group. The stock's current Portfolio Grader ranking places it 120 among the 133 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 679 among the 781 companies in the sector, and number 4,148 in the nearly 5,000 company Portfolio Grader universe.

DowDuPont’s (DWDP) Raised to Buy

By Portfolio Grader
The current recommendation of Buy for DowDuPont Inc (NULL:DWDP) has been derived by using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Verizon (VZ) a Hold on Pallid Earnings Visibility

By Portfolio Grader
Portfolio Grader currently ranks Verizon Communication Inc (NYSE:VZ) a Hold. With unique fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool assesses nearly 5,000 stocks weekly. VZ has maintained this ranking for 3 months.

Novartis AG (NVS) a Buy on Solid Earnings Visibility

By Portfolio Grader
Novartis AG (NYSE:NVS) is classified as a constituent of the 133 company Pharmaceuticals GICS industry group, which is a segment of the 781 company GICS Health Care sector. NVS has a market value of $195.5 billion which is in the top 10% of its industry group. Currently, the stock's Portfolio Grader ranking places it 23 among the 133 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 166 among the 781 companies in the sector, and number 1,096 in the nearly 5,000 company Portfolio Grader universe.

Sagging Earnings Visibility Drops China Mobile (CHL) to Hold

By Portfolio Grader
Portfolio Grader currently ranks China Mobile Ltd (NYSE:CHL) a Hold. The methodology for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Improving Earnings Growth Analytics Drive Upgrade of Pfizer (PFE) to Buy

By Portfolio Grader
Pfizer Inc (NYSE:PFE) is one of 133 companies within the Pharmaceuticals GICS industry group, which is in turn part of the 781 company GICS Health Care sector. PFE has a market value of $210.8 billion which is in the top 10% of its industry group. The ranking for PFE by Portfolio Grader places it 35 among the 133 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 206 among the 781 companies in the sector, and number 1,335 in the nearly 5,000 company Portfolio Grader universe.

AT&T (T) a Sell on Flagging Earnings Visibility

By Portfolio Grader
AT&T Inc (NYSE:T) is a $211.9 billion in market value component of the Diversified Telecommunication Services GICS industry group where the stock's Portfolio Grader ranking currently places it 37 among the 45 companies in this industry group, a spot that is well below-average. T is ranked squarely in the bottom quartile of the sector with a ranking of 54 among the 66 companies in the sector and number 3,611 in the 5000 company Portfolio Grader company universe.

Chevron (CVX) a Buy on Solid Sales Growth

By Portfolio Grader
Currently, Chevron Corp (NYSE:CVX) has a Buy using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking CVX has had from Portfolio Grader for 4 months.
Load More Articles